Atorvastatin reduced coronary and stroke events in patients with hypertension and without dyslipidemia

Affiliations

Comment

Joel A Simon. ACP J Club. 2003 Nov-Dec.

. 2003 Nov-Dec;139(3):57.

¹ San Francisco Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, California, USA.

No abstract available

Comment in

Atorvastatin reduced coronary and stroke events in patients with hypertension and without dyslipidemia.
Tayek J. Tayek J. ACP J Club. 2004 Mar-Apr;140(2):A16; author reply A16. ACP J Club. 2004. PMID: 15122876 No abstract available.

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators. Sever PS, et al. Lancet. 2003 Apr 5;361(9364):1149-58. doi: 10.1016/S0140-6736(03)12948-0. Lancet. 2003. PMID: 12686036 Clinical Trial.